期刊文献+

抗环瓜氨酸肽抗体与类风湿关节炎疾病活动及骨侵蚀关系的研究 被引量:28

Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease activity and bone erosion
原文传递
导出
摘要 目的探讨类风湿关节炎(RA)患者抗环瓜氨酸肽(CCP)抗体、类风湿因子(RF)与疾病活动度、功能状态及骨侵蚀的关系。方法人选RA患者218例,健康对照41名,ELISA法检测抗CCP抗体,乳胶凝集法检测RF,同时记录RA患者的临床资料。分析抗CCP抗体、RF阳性和阴性患者中疾病活动指数28(DAS28)、健康评估问卷(HAQ)的变化,并探讨其中124例病程〉2年的患者抗CCP抗体、RF与骨侵蚀的关系。结果RA患者中抗CCP抗体阳性率为76%,RF阳性率勾71%。DAS28评分在抗CCP抗体、RF阳性患者明显高于阴性患者(P〈0.05);抗CCP抗体浓度与DAS28评分相关(r=0.385,P=0.032);RF滴度与DAS28评分相关(r=0.141,P=0.037);红细胞沉降率(ESR)、C反应蛋白(CRP)及HAQ评分在抗CCP抗体、RF阳性和阴性患者之间的差异无统计学意义(P〉0.05)。抗CCP抗体阳性患者更易出现骨侵蚀,与阴性患者相比。差异有统计学意义(P〈0.05)。RF阳性和阴性患者之间骨侵蚀的差异无统计学意义。结论抗CCP抗体、RF与疾病活动度相关,抗CCP抗体阳性患者更易出现骨侵蚀,但RF与骨侵蚀未表现出相关性。 Objective To compare the correlation between anti-cyclic eitrullinated peptide antibody (anti-CCP), rheumatoid factor (RF) and disease activity, functional capacity, bone erosion of rheumatoid arthritis (RA). Methods The correlation between anti-CCP, RF and disease activity score 28 (DAS28), health assessment questionnaire(HAQ) and bone erosion was assessed. Results Among the 218 RA patients, 76% were anti-CCP-positive and 71% were RF-positive. The mean DAS28 score of RA patients with anti-CCP-positive and RF-positive was significantly higher than patients without anti-CCP and RF. The serum anti-CCP levels and RF levels showed a significant correlation with DAS28 score. However, the HAQ scores, ESR and CRP levels showed no significant difference between anti-CCP-positive and anti-CCP-negative patients. RF-positive and RF-negative patients. Among anti-CCP-positive RA patients, the number of patients with erosive disease was significantly higher than patients without anti-CCP. However, the number of patients with erosive disease was not significantly different between RF-positive and RF-negative patients. Conclusion Anti-CCP and RF are associated with disease activity. Anti-CCP is associated with bone erosion. No association is found between RF and bone erosion.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第9期603-605,共3页 Chinese Journal of Rheumatology
基金 基金项目:山西省闩然科学基金资助项目(2007011116) 山西省卫生厅科技攻关资助项目(200614) 山西省科技攻关资助项目(2007031093-4)
关键词 关节炎 类风湿 抗环瓜氨酸肽抗体 疾病活动指数28 健康评估问卷 骨侵蚀 Arthritis, rheumatoid Anti-cyclic citrullinated peptide antibody Disease activity soore 28 Health assessment questionnaire Bone erosion
  • 相关文献

参考文献11

  • 1Bas S, Perneger TV, Seitz M, et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cycLic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factor. Rheumatology (Oxford), 2002, 41: 809-814.
  • 2Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 3Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic disease. Ann Rheum Dis, 2003, 62: 870-874.
  • 4Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum, 2004, 50: 709-715.
  • 5Silveira IG, Burlingame RW, yon Muhlen CA, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol, 2007, 26: 1883-1889.
  • 6Quinn MA, Goagh AK, Green M J, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology ( Oxford ), 2006, 45:478 -480.
  • 7del Val del Amo N, Ibanez-Bosch R, Fito-Manteca C, et al. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol, 2006, 24: 281-286.
  • 8Inanc N, Dalkilic E, Kamali S, et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol, 2007, 26: 17-23.
  • 9Bas S, Genevay S, Meyer O, et al. Anti-cyclic citrullinated peptide antibodies, IgM and lgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford), 2003, 42: 677-680.
  • 10Van der Hehn-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical prngression of rheumatoid arthritis. Arthritis Res Ther, 2005, 7: 949-958.

同被引文献207

引证文献28

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部